Mostrar el registro sencillo del ítem

dc.contributor.authorLópez Arencibia, Atteneri
dc.contributor.authorBethencourt Estrella, Carlos Javier
dc.contributor.authorBlanco Freijo, Mónica
dc.contributor.authorReyes Batlle, María
dc.contributor.authorSifaoui, Inés 
dc.contributor.authorSan Nicolás Hernández, Desirée
dc.contributor.authorMcNaughton Smith, Grant
dc.contributor.authorLorenzo Morales, Jacob 
dc.contributor.authorAbad-Grillo, Teresa 
dc.contributor.authorPiñero Barroso, José Enrique 
dc.date.accessioned2024-01-29T21:07:10Z
dc.date.available2024-01-29T21:07:10Z
dc.date.issued2020
dc.identifier.issn0753-3322
dc.identifier.urihttp://riull.ull.es/xmlui/handle/915/35821
dc.description.abstractThe in vitro activity against Leishmania spp. of five novel designed compounds, phenalenone derivatives, is described in this study. Previous works have shown that some phenalenones present leishmanicidal activity, some of which could induce programmed cell death events in L. amazonensis parasites. In this research, we focused on the determination of the programmed cell death evidence by detecting the characteristic features of the apoptosis-like process, such as phosphatidylserine exposure and mitochondrial membrane potential, among others. The results showed that the new derivatives have comparable or better activity and selectivity than the commonly prescribed anti-leishmanial drug. This result was obtained by inducing stronger mitochondrial depolarization or more intense phosphatidylserine exposure than miltefosine, highlighting compound 8 with moreover 9-times better selectivity index. In addition, the new five molecules activated the apoptosis-like process in the parasite. All the signals observed were indicative of the death process that the parasites were undergoing.en
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.relation.ispartofseriesBiomedicine & Pharmacotherapy Volume 132, 2020, 110814
dc.rightsLicencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es_ES
dc.titleNew phenalenone analogues with improved activity against Leishmania species.
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.biopha.2020.110814
dc.subject.keywordPhenalenonesen
dc.subject.keywordLeishmania amazonensisen
dc.subject.keywordapoptosis-likeen
dc.subject.keywordchemotherapyen


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)
Excepto si se señala otra cosa, la licencia del ítem se describe como Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)